Cytos Biotechnology AG (CYTN.S) Quote| Reuters.com
Edition:
United States

Cytos Biotechnology AG (CYTN.S)

CYTN.S on Swiss Exchange

--CHF
--
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,881
52-wk High
CHF65.00
52-wk Low
CHF20.00

CYTN.S

Chart for CYTN.S

About

Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic... (more)
No analyst recommendations are available for CYTN.S.

Overall

Beta: 1.60
Market Cap(Mil.): CHF149.99
Shares Outstanding(Mil.): 5.08
Dividend: --
Yield (%): --

Financials

  CYTN.S Industry Sector
P/E (TTM): 7.05 38.82 34.11
EPS (TTM): 4.18 -- --
ROI: -- -5.72 14.23
ROE: -- -4.83 15.46

BRIEF-Cytos Biotechnology to be renamed Kuros Biosciences Ltd, appoints new CEO

* Will be renamed Kuros Biosciences Ltd., constitutes its board of directors and appoints executive officers

Jan 08 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Edison Investment Research
$10.00
Provider : Directors Deals Ltd.
$12.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.